IRulya Therapeutics Inc. (IRLA) stock
Close on Nov 13, 2026Market cap $40.48MP/E –Yield –
IRulya Therapeutics statistics
58 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 11, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 254.7%
- 10.8%
- Shares Change (QoQ)
- 0.00%
- 0.50%
- Shares Held by Institutions
- 32.5%
- 56.4%
Short sellingIndustry
- Short Interest
- 127,816
- –
- Short Interest Change
- -17.4%
- -0.80%
- Short % of Shares Outstanding
- 12.6%
- 6.30%
- Days to Cover
- 1.13
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $909.98
- –
- 52-Week Low
- $15.10
- –
- 20-Day Moving Average
- $34.28
- –
- 50-Day Moving Average
- $31.58
- –
- 200-Day Moving Average
- $27.06
- –
- Average True Range (14)
- $4.31
- –
- Price Change (1 Week)
- 28.4%
- -1.15%
- Price Change (1 Month)
- 19.8%
- -4.87%
- Price Change (3 Months)
- 16.6%
- -21.0%
- Price Change (6 Months)
- 73.0%
- -20.6%
- Price Change (YTD)
- -94.1%
- -23.6%
- Price Change (1 Year)
- -88.4%
- -22.4%
- Price Change (3 Years)
- -77.8%
- -29.5%
- Price Change (5 Years)
- -98.6%
- -77.9%
- Average Volume (10 Days)
- 94,379
- –
- Average Volume (20 Days)
- 109,047
- –
- Average Volume (90 Days)
- 48,621
- –
- Relative Volume
- 1.15
- 0.70
- Relative Strength Index (14)
- 63.9
- 43.4
- Volatility (1 Year)
- 355.2%
- 80.1%
- Beta (5 Years)
- 1.02
- 1.07
Returns on capitalIndustry
- Return on Assets (ROA)
- -98.7%
- -40.6%
- Return on Capital Employed (ROCE)
- -127.8%
- -37.9%
Financial positionIndustry
- Current Ratio
- 14.72
- 3.30
- Quick Ratio
- 14.57
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$2.81M
- -$689.41K
- Employee Count
- 38
- 74
- WACC
- 10.2%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $105.20M
- $17.76M
- Net Cash Per Share
- $103.44
- $0.80
- Equity (Book Value)
- -$65.71M
- $53.89M
- Book Value Per Share
- -$64.60
- $1.50
- Tangible Book Value
- -$65.71M
- $27.13M
- Working Capital
- $99.08M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$75.00K
- -$1.00M
- FCF Per Share
- -$46.12
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -263.8%
- -21.8%
- FCF Yield
- -115.9%
- -9.44%
Taxes and interestIndustry
- Income Tax
- -$2.42M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -8.90
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | IRLA | S&P 500 | Difference | IRLA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +42.8% | -3.0% | +45.8 pts | ||
| 3 months | +22.8% | -2.8% | +25.6 pts | ||
| Year to date | -94.1% | +11.5% | −105.5 pts | ||
| 1 year | -88.2% | +13.5% | −101.6 pts | ||
| 3 years | -78.1% | +77.7% | −155.8 pts | -39.7% | +21.1% |
| 5 years | -98.6% | +72.6% | −171.2 pts | -57.4% | +11.5% |
| 10 years | -97.9% | +308.2% | −406.1 pts | -32.1% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M IRLA shares were sold short on Oct 30, 2026, down 17.4% from the previous report. At recent volumes it would take 1.1 days to buy them back. Over the last 20 sessions, 41.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 127,816 | -17.4% | 112,687 | 1.1 |
| Oct 15, 2026 | 154,736 | +158.1% | 46,846 | 3.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?